The combination of a chemotherapy doublet (gemcitabine and...

European Journal of Cancer 2014 / 05 Vol. 50; Iss. 8

The combination of a chemotherapy doublet (gemcitabine and capecitabine) with a biological doublet (bevacizumab and erlotinib) in patients with advanced pancreatic adenocarcinoma. The results of a phase I/II study

Watkins, D.J., Starling, N., Cunningham, D., Thomas, J., Webb, J., Brown, G., Barbachano, Y., Oates, J., Chau, I.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
50
Language:
english
Journal:
European Journal of Cancer
DOI:
10.1016/j.ejca.2014.02.003
Date:
May, 2014
File:
PDF, 446 KB
english, 2014
Conversion to is in progress
Conversion to is failed